603363 傲农生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-0.4282.72572.273-473.325-54.521
总资产报酬率 ROA (%)-0.1520.8515.009-22.614-5.807
投入资产回报率 ROIC (%)-0.2351.3618.532-36.180-8.807

边际利润分析
销售毛利率 (%)4.2516.2864.518-4.7394.387
营业利润率 (%)-1.7731.1544.764-18.759-6.068
息税前利润/营业总收入 (%)-0.6302.8998.428-15.990-3.528
净利润/营业总收入 (%)-1.9411.0550.720-19.369-5.672

收益指标分析
经营活动净收益/利润总额(%)205.520-209.082-1,746.76874.77866.584
价值变动净收益/利润总额(%)-128.478491.4582,384.2340.1119.248
营业外收支净额/利润总额(%)-2.9657.147-394.0220.855-1.263

偿债能力分析
流动比率 (X)0.9290.9340.8020.2460.439
速动比率 (X)0.6220.6660.6250.1290.157
资产负债率 (%)60.34759.04667.798103.69381.596
带息债务/全部投入资本 (%)40.15939.30848.79292.04463.425
股东权益/带息债务 (%)135.691140.22591.769-13.32732.036
股东权益/负债合计 (%)57.99960.64839.817-6.81616.453
利息保障倍数 (X)-0.5761.7501.129-5.456-1.432

营运能力分析
应收账款周转天数 (天)25.06619.17821.38510.7608.677
存货周转天数 (天)45.11040.16946.14840.77751.196